This content is from: Portfolio A Jim Simons Market Mystery — Solved? A secretive investment fund backed by the legendary quant displays a penchant for biotech stocks. There’s a good reason for that. By Richard Teitelbaum February 07, 2023
This content is from: Research These Are America’s Best Independent Research Providers MoffettNathanson leads Institutional Investor’s new ranking of boutique research firms. By Grace Chung February 07, 2023
This content is from: Research Canada’s Top CEOs Turn Challenges Into Opportunities Members of II’s 2023 All-Canada Executive Team discuss how technology and sustainability will drive future business. By Grace Chung December 06, 2022
This content is from: Premium These Are the Most Popular Hedge Fund Stocks A new company tops SEI Novus’s exhaustive ranking of the 15 stocks with the most hedge fund managers. By Stephen Taub August 24, 2022
This content is from: Premium Quants Snap Up Snap Several of the largest computer-driven hedge funds were the biggest buyers of the social media company in the second quarter. By Stephen Taub August 31, 2022
Sponsored Reality Check For Cash-Heavy Renaissance Renaissance Technologies founder James Simons is finding that being bigger doesn’t always add up to better returns. December 19, 2006
